HIGHLIGHTS
- who: Maria Antonietta Barbieri and collaborators from the Azienda Usl Toscana nord ovest, Italy Carol Davila University of Medicine have published the article: Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database, in the Journal: (JOURNAL) of December/31,/2021
- what: The aim of this study was to analyze the onset of adverse drug reactions (ADRs) related to TKIs in NSCLC through a spontaneous reporting system (SRS) database. The aim of this study was 1) to highlight all Italian open data-related ADRs associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.